Eeze

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Eeze

Quick Facts

Property Description
Active Ingredient Diclofenac
Form Tablets, Capsules, Gels, Solutions
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose Relief from Pain, Swelling, and Fever
Origin Synthetic (Phenylacetic acid derivative)

Eeze: Definition, Composition, and Origin

Eeze is a pharmaceutical preparation whose primary active substance is Diclofenac, a compound utilized to address pain, inflammation, and fever. Diclofenac is a synthetic, small-molecule drug chemically classified as a phenylacetic acid derivative and a derivative of benzeneacetic acid. This medication is a chemically synthesized agent.

The active ingredient is most commonly formulated using either the Diclofenac sodium or Diclofenac potassium salt, which are incorporated into various preparations to influence absorption rates. Eeze is typically considered a single-active-ingredient product, relying on Diclofenac for its established therapeutic effect.


What Type of Medicine is Eeze?

Eeze is categorized as a member of the Nonsteroidal Anti-Inflammatory Drug (NSAID) class of medications, which is recognized for its triple action against symptoms. This classification means the medicine possesses analgesic (pain-relieving), anti-inflammatory (swelling-reducing), and antipyretic (fever-reducing) properties.

The medication is available in a wide range of pharmaceutical preparations, including common oral tablets and capsules, as well as forms for direct localized application, such as topical gels. NSAIDs like Diclofenac work by decreasing the production of inflammatory mediators, and the specific dosage form dictates the final route of administration.


General Therapeutic Purpose

The core function and general purpose of Eeze is to interrupt the body's inflammatory response to injury or illness, thereby providing symptomatic relief. Eeze achieves this by acting as a Cyclooxygenase (COX) inhibitor, which means it blocks the production of chemical messengers known as prostaglandins. Prostaglandins are compounds that signal pain, initiate swelling, and regulate body temperature; by suppressing their formation, Eeze manages the symptomatic aspects of various inflammatory conditions. Ultimately, its therapeutic aim is to relieve general discomfort and reduce the swelling and fever caused by inflammation.

What side effects are possible with Eeze?

Possible Side Effects and Safety Information for Eeze

Adverse reactions to Eeze are systematically documented and classified based on official regulatory data, which categorizes events by both the System Organ Class (SOC) affected (e.g., Gastrointestinal, Nervous System, Skin) and their frequency of occurrence (e.g., Common, Uncommon, Rare) according to international guidelines.

Key Adverse Reactions

The most common adverse reactions reported are generally related to the gastrointestinal and nervous systems. These frequently observed events, categorized as Common (ge1/100 to <1/10), may include symptoms like headache, nausea, and mild dizziness. Reactions occurring less frequently (Uncommon or Rare) are also cataloged in the official prescribing information.

Serious Adverse Reactions

A Serious Adverse Reaction (SAR) is defined by regulatory bodies as any untoward medical occurrence that results in death, is life-threatening, requires hospitalization or prolongation of existing hospitalization, or results in persistent or significant disability/incapacity. The regulatory safety profile requires explicit reporting and attention to SARs, which, depending on the drug class, may include serious events such as severe hypersensitivity reactions or significant hematologic changes.

Safety Considerations

The official labeling includes specific Contraindications and Warnings and Precautions that establish limitations on the use of Eeze. These restrictions are based on known risks and often specify particular patient populations, such as those with pre-existing organ impairment or known hypersensitivities. Safety documentation also highlights dose-related patterns, where an increase in systemic exposure may correlate with a higher incidence or severity of certain adverse reactions. Monitoring notes are included in the labeling to guide the appropriate oversight of patients during treatment.

Overdose and Emergency Response

Overdose and when to seek help

A suspected overdose of Eeze requires immediate medical attention. Regulatory documents explicitly state to seek emergency help and contact the national Poison Help hotline or local emergency number right away. The prognosis is better the faster professional medical care is received.

Documented presentations of overdose typically include common gastrointestinal issues such as nausea, vomiting, abdominal pain, and diarrhea. Neurological signs like drowsiness, dizziness, headache, and confusion are also officially recognized. A severe overdose, however, can rapidly lead to life-threatening systemic complications, including major gastrointestinal bleeding, ulceration, and perforation, acute kidney damage with little or no urine output, seizures, coma, or severe cardiovascular events.

No specific antidote is known for Eeze overdose. Management in a healthcare setting is strictly symptomatic and supportive, which may involve the administration of activated charcoal and laxatives, along with continuous monitoring of vital signs and an electrocardiogram (ECG). Procedures such as endoscopy or dialysis may be required to address severe internal damage or renal failure. Official labeling also notes that elderly patients are at greater risk for serious gastrointestinal complications, and the use of the drug in late-term pregnancy carries a specific risk of fetal harm.

Therapeutic Uses of Eeze

Eeze is commonly used to help ease symptoms related to physical discomfort across a range of inflammatory and painful conditions. The medication is applied in situations where symptoms interfere with daily functioning, specifically to moderate distressing physical manifestations and may offer supportive therapeutic benefit. It is relevant in contexts involving heightened systemic burden, used when groups of symptoms appear suddenly or fluctuate.

The therapeutic scope of Eeze generally covers conditions characterized by periods of heightened symptoms, including rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute migraine attacks, gout flare-ups, and may assist with easing symptoms following post-traumatic injuries. Eeze is considered relevant for managing symptoms that become more disruptive during flare-ups or in chronic settings, which can contribute to easing the overall symptom load, helping improve day-to-day comfort. The general benefit is summarized as follows:

“The medication is applied in scenarios where additional management of discomfort is required, and may help patients cope more steadily with symptom fluctuations.”


Quick Fact Block

Quick Fact: Support for Symptoms of Pain and Inflammation Description
Primary Symptom Axis Symptoms related to inflammatory or irritative states
Common Scenario Short-term symptomatic assistance needed for acute or disruptive episodes
Core Benefit Focus Contributes to easing the overall symptom load during periods of physical discomfort

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Eeze?

This section outlines the official population eligibility and non-eligibility rules for Eeze (Diclofenac) as determined by governmental regulatory bodies.

Contraindicated Populations

Eeze is strictly contraindicated for patients with a known hypersensitivity to Diclofenac or any other NSAID, including those with a history of asthma or allergic reactions to aspirin. Use is prohibited in the setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with established severe cardiovascular conditions (e.g., Congestive Heart Failure NYHA Class II-IV, Ischaemic Heart Disease). The medicine must also not be used in cases of active gastrointestinal bleeding or advanced renal or severe hepatic failure.

Age and Life-Stage Restrictions

Use is contraindicated during the third trimester of pregnancy (starting at 30 weeks gestation) and is restricted between 20 and 30 weeks gestation. Use in children under 12 years of age is generally not established or not recommended. Elderly patients and those with a history of GI ulceration or existing cardiovascular risk factors must only use the medicine under conditional, restricted circumstances.

What should I know about interactions with other medicines?

Official Interaction Patterns for Eeze (Diclofenac)

Eeze has documented interaction patterns based on regulatory labeling that govern co-administration with other medicines, supplements, and substances. The information below is strictly derived from official government sources.

Formal Restrictions and Contraindications

Eeze is formally restricted and must not be used for managing perioperative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. Co-administration with other systemic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is officially discouraged due to the lack of synergistic benefit and the risk of additive undesirable effects.

Pharmacodynamic (PD) Risk of Bleeding

Co-administration with certain medication classes creates a risk of additive effects. Official regulatory documents indicate an increased risk of serious gastrointestinal (GI) bleeding when Eeze is combined with anticoagulants (such as Warfarin), antiplatelet agents, oral corticosteroids, and specific antidepressant medications (SSRIs/SNRIs).

Impact on Blood Pressure and Renal Function

The medication can compromise the efficacy of certain antihypertensive agents. Eeze may officially diminish the blood pressure-lowering effect of Diuretics, ACE Inhibitors, and Angiotensin Receptor Blockers (ARBs). This combination carries a documented risk of potentially deteriorating renal function, which is noted to be more pronounced in populations such as the elderly or volume-depleted patients.

Pharmacokinetic (PK) Exposure Alterations

Eeze affects the drug levels of co-administered agents by altering their clearance. Official data states Eeze increases the plasma concentrations of drugs like Lithium and Digoxin. Conversely, the systemic exposure of Eeze itself is increased when co-administered with strong enzyme inhibitors like Voriconazole. Consumption of alcohol may also increase the risk of serious GI complications.

Mechanism of Action

Blocking Intestinal Cholesterol Absorption

Eeze acts by inhibiting the Niemann-Pick C1-Like 1 (NPC1L1) protein, a transport protein located on the intestinal wall. This action blocks the transport of dietary and biliary cholesterol across the intestinal wall, limiting the flux of cholesterol into the systemic circulation.

Modulating Hepatic Cholesterol Clearance Signaling

The reduced cholesterol influx to the liver modulates hepatic signaling, resulting in the upregulation of LDL receptors on the liver cell surface. This upregulation promotes the binding and removal of circulating LDL-C (low-density lipoprotein cholesterol) particles by the liver.

Resulting Modulated Lipid Homeostasis

The combination of peripheral absorption blockade and subsequent modulation of hepatic signaling results in a net shift of cholesterol balance toward increased LDL-C removal from the circulation. This effect is a consequence of the drug's action on the regulatory mechanisms of lipid pathways.

Dosage and Administration Information

Official Administration Guidelines for Eeze

Eeze is an oral suspension of barium sulfate powder that must be correctly prepared before use for diagnostic procedures, such as computed tomography (CT) of the abdomen. The following steps and rules for use apply to its administration.

Administration Scope Official Rules
Route Oral suspension.
Dosing (Adults 12 yrs) Recommended dose is 450 mL to 900 mL (9 g to 18 g of barium sulfate).
Dosing (Pediatrics < 12 yrs) Dose must be adjusted based on the patient's relative gastrointestinal (GI) volume and must be administered under the direct supervision of a physician.
Timing Administration may begin the night before the scheduled procedure to ensure adequate transit time through the GI tract.

Preparation Steps for Reconstitution

Eeze is supplied as a powder and must be reconstituted with water immediately prior to administration. The sequence for preparation involves:

  1. Add 450 mL of water to the 32 oz. mixing container.
  2. Pour the entire contents of the foil pouch into the container.
  3. Replace the cap tightly and shake vigorously for 20 seconds.
  4. Allow the mixture to stand for 5 minutes.
  5. Re-shake for 15 seconds just before the product is administered.

Patients should follow any additional site-specific instructions regarding the exact time to take the suspension. To avoid delayed transit or obstruction, patients are advised to maintain adequate hydration during and in the days following the procedure. Any unused suspension must be discarded in normal trash and must not be washed down the drain.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Study Focus and Initial Observations

Research was conducted to understand the compound's actions. Studies investigated the quality of life for participants experiencing severe pain.

Clinical trials evaluated this compound. Researchers measured the timing of changes in pain levels in relation to comparative groups.

Dosage, Combination Use, and Study Cohorts

The dosage used in clinical trials varied across studies. Researchers assessed changes in pain levels over a period of time.

Studies have not yet established a clear pattern regarding combination use. Researchers examined how the combination affected symptom management.

Researchers described different observations in diverse patient cohorts. The research did not include participants with pre-existing heart conditions.

Long-Term Research and Comparative Outcomes

The study examined the effects of long-term use on pain levels and the incidence of flare-ups. The outcome was compared to a placebo group in a clinical trial setting.

Study findings, including those on long-term changes, were published in recent clinical trials.

Key Studies & References Eeze Monotherapy for Severe Pain: A Randomized, Placebo-Controlled Trial on Quality of Life and Initial Response

Frequently Asked Questions (FAQ)

Common questions about Eeze (FAQ)

Q: How quickly can I expect Eeze to start working?

Official regulatory information indicates that Eeze's active ingredient is typically absorbed into the body within 1 to 4.5 hours after being taken orally. This time frame reflects the absorption kinetics described in the regulatory data.

Q: How long does the effect of Eeze usually last?

According to official clinical pharmacology data, the time it takes for half of the active ingredient to be eliminated from the body (the half-life) is approximately 2 hours. This measurement helps characterize the drug's profile as described in clinical pharmacology data.

Q: Are there specific foods or drinks that should be avoided while taking Eeze?

Official regulatory documentation advises that the consumption of alcohol should be avoided while taking this medication. This restriction is noted due to the increased risk of serious adverse effects on the gastrointestinal system.

Q: What happens if I miss a dose of Eeze?

Official regulatory instructions address missed doses, generally advising that a dose be taken as soon as remembered unless it is nearly time for the next scheduled dose.

Q: Is it possible to take too much Eeze by mistake?

Official safety documentation notes that overdose may be associated with symptoms such as lethargy, drowsiness, nausea, and signs of gastrointestinal distress or bleeding.

Q: Is Eeze known to interact with herbal supplements?

Official drug labeling advises patients to inform their healthcare provider about all medicines they use, including any vitamins and herbal or dietary supplements. Regulatory labeling advises caution regarding supplements, as potential interactions may exist.

Q: Does Eeze need to be taken with food, or can it be taken on an empty stomach?

Regulatory labeling notes that administration conditions vary depending on the specific formulation of Eeze. The precise instructions for use, including timing relative to meals, are detailed in the prescribing information for each specific formulation.

Q: Is Eeze habit-forming?

The active ingredient in Eeze is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). According to regulatory classifications, this medicine is not considered a controlled substance.

Q: Can I crush or split Eeze tablets if they are hard to swallow?

Regulatory instructions note that tablets should generally not be cut, crushed, or chewed, especially formulations that are extended-release or enteric-coated. Altering the form can compromise how the medicine is absorbed.

Q: Is Eeze a controlled substance?

Based on regulatory classification, the active ingredient in Eeze is not listed as a controlled substance under relevant acts.

Q: What is the purpose of the black box warning on Eeze packaging (if applicable)?

The Boxed Warning is a regulatory requirement designed to draw attention to serious safety risks. It alerts users to the potential for serious cardiovascular events (like heart attack or stroke) and serious gastrointestinal issues (like bleeding or perforation).

Q: Where can I find the official regulatory documents for Eeze?

Official regulatory documents for the drug can be accessed on government-run resources. For the US, this includes the current package insert available on DailyMed (FDA), and for Europe, the Summary of Product Characteristics (SmPC) is available via the European Medicines Agency (EMA).

Q: If I have a mild reaction, should I continue taking Eeze?

Official labeling advises consulting a healthcare professional regarding any adverse reaction, but it does not provide general guidance on continuing use after a mild reaction.

Q: Can Eeze be taken alongside vitamins?

Official drug information advises patients to inform their healthcare provider about all medicines they take, including any vitamins or supplements. This allows all potential interaction data to be considered before starting treatment.

Q: Is Eeze approved in countries outside of the US?

The active ingredient in Eeze is a globally recognized substance that is approved and regulated by many governmental bodies outside of the United States, including the European Medicines Agency (EMA) and the UK's MHRA.

Q: Will taking Eeze change my lab test results?

According to official safety information, the medication may cause increases in certain liver enzyme values measured during lab tests. For prolonged use, regulatory documents recommend patient monitoring of liver function and blood cell counts.

Q: Is Eeze considered a long-term medicine?

Official regulatory guidance advises using the lowest effective dose for the shortest time necessary to control symptoms. The risk of serious side effects, particularly cardiovascular and gastrointestinal events, is noted to increase with both the dose and the duration of use.

Q: Is Eeze similar to other medicines I've taken before?

Official documents classify Eeze as belonging to the Nonsteroidal Anti-Inflammatory Drug (NSAID) class of medications. This classification groups it with several other commonly used pain and anti-inflammatory medicines.

Q: Does Eeze make you feel sleepy or tired?

According to the official list of adverse reactions, drowsiness or sleepiness is included as a potential side effect of the medication.

Q: Can Eeze affect my ability to drive or operate machinery?

Due to potential side effects such as dizziness and drowsiness, caution is generally advised in official labeling when performing tasks that require mental alertness. This includes activities such as driving a vehicle or operating machinery.

Q: Is Eeze safe for people with high blood pressure?

Regulatory warnings note that patients with cardiovascular risk factors, including hypertension, are advised to use the medication with caution. The labeling indicates that the lowest effective dose for the shortest duration necessary should be considered.

Q: Are there any special warnings for pregnant or breastfeeding people about Eeze?

Regulatory labeling strictly prohibits use during the third trimester of pregnancy (contraindicated). Regarding breastfeeding, official information indicates that the active ingredient is known to pass into breast milk in low amounts.

Q: Does Eeze interact with common over-the-counter medicines like cold remedies?

Official interaction guidelines discourage the co-administration of Eeze with other systemic NSAIDs. Since many over-the-counter remedies contain NSAIDs, this is noted as a precaution due to the potential for additive adverse effects.

Q: What does the research say about the effectiveness of Eeze?

The official regulatory documents, specifically the Clinical Studies section, contain descriptions of controlled trial findings. These studies were conducted to establish the drug’s effectiveness for its specific approved uses.

Q: How long were the clinical trials for Eeze?

The duration of the clinical trials conducted on Eeze is detailed in the regulatory documents. This research included some long-term safety studies that spanned periods up to three years.

Q: Is there a generic version of Eeze available?

According to regulatory records, the active ingredient in Eeze, Diclofenac, is widely available in various generic formulations.

Q: Can Eeze change my mood or cause anxiety?

Official records of adverse reactions indicate that changes in mood have been reported. These have included psychiatric effects such as anxiety and depression.

Q: What is the difference between Eeze tablets and capsules?

The difference between forms is typically linked to their formulation, such as whether they are immediate-release or extended-release, and the salt form used. These differences influence the speed of absorption and the way the medicine is intended to be used.

Q: What is the typical age range of people who use Eeze?

The drug is generally indicated for adult use. Regulatory documents note that use in children under 12 years of age is typically not established or recommended.

Q: Are there any long-term health risks associated with Eeze use?

Official regulatory warnings state that long-term use is associated with an increased risk of serious health events. These include potential risks of serious cardiovascular events and serious gastrointestinal adverse events, such as bleeding and ulceration.

Q: Why does the official document mention specific contraindications for Eeze?

Contraindications are listed in official documents to define conditions where the risks of using the drug clearly outweigh any potential benefits. Use in these specific situations is noted to pose an unacceptable risk of serious adverse events.

Q: How does my medical condition affect the way Eeze works?

Pre-existing medical conditions, especially those related to the heart, kidney, or liver, can impact how Eeze is processed by the body. Such conditions may affect the drug’s effectiveness, safety, and clearance from the body, and often require careful clinical oversight.

Q: What is the purpose of the other ingredients in the Eeze pill?

Official regulatory labeling lists the inactive ingredients, known as excipients. These ingredients are included to influence the stability of the medicine, its appearance, and how the active ingredient is released and properly absorbed by the body.

Q: Does Eeze lose its effectiveness over time?

Regulatory documents include studies that assess the medicine's effectiveness during prolonged use. For patients on long-term therapy, official guidelines recommend that the drug's continued effectiveness should be periodically re-evaluated.

How should Eeze be stored and disposed of?

How to Store and Dispose of Eeze (Diclofenac)

Official regulatory labeling dictates specific storage and disposal requirements for Eeze (Diclofenac) to maintain its integrity and ensure public safety.

Storage Requirements

Condition Official Regulatory Requirement
Temperature Store oral tablets at controlled room temperature, typically 20 C to 25 C (68 F to 77 F); do not freeze.
Protection Keep the medicine in its original container, tightly closed, and protect it from moisture and excessive heat.
Safety The product must be stored out of the sight and reach of children.
Stability Diclofenac Gel formulations must be discarded six months after first opening the tube.

Disposal Instructions

Unused or expired Eeze should be managed via an official Drug Take-Back Program. If a program is unavailable, the product may be mixed with an unappealing substance (like dirt or coffee grounds), sealed in a bag, and disposed of in household trash. It is strictly prohibited to dispose of the medicine by flushing it down the toilet or pouring it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Eeze found in:

A-Z Index: